ESP Block in MIS Lumbar Spine Surgery

Part of paid clinical trials in New York, New York.

Sponsor
Hospital for Special Surgery, New York
Study ID
NCT05856539
Status
Recruiting
Apply to this trial

Conditions

  • Patients With Spinal Stenosis Indicated for MIS TLIF

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Erector spinae plane (ESP) block — PROCEDURE
    ESP block is an opioid-sparing regional anesthetic involving bupivacaine and dexamethasone for lumbar spinal surgery with touted benefits including opioid use reduction and improved pain control.

Study Details

This is a prospective, randomized controlled trial of patients undergoing minimally invasive transforaminal lumbar interbody fusion. This study will randomize patients into one of two groups: erector spinae plane (ESP) block and no ESP block.

Key Dates

Start date
May 15, 2023
Status verified
Sep 2025
Primary completion
Jul 15, 2026
Completion
Jul 15, 2026

Study Design

Enrollment
48 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: ESP Block
    Patients assigned to the "ESP Block" arm will receive an ESP block prior to the surgery.
  • No Intervention: Control
    Patients assigned to the "Control" group will not receive an ESP block prior to the surgery.

Primary Outcome Measure

24-hour oral morphine milligram equivalents (OMEs) [ Time Frame: 24 hours postoperatively ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Hospital for Special SurgeryNew YorkNew York10021
Sheeraz Qureshi, MD, MBA
[email protected]
919-260-9699
Patawut Bovonratwet, MD (SUB_INVESTIGATOR)
Douglas Wetmore, MD (SUB_INVESTIGATOR)
Sheeraz Qureshi, MD, MBA (PRINCIPAL_INVESTIGATOR)

Find similar trials in New York, NY

By research site
Hospital for Special Surgery· New York, NY